Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
The Alloimmune Disorders of Pregnancy
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Kristina Deligiannidis, MD
Jennifer L. Payne, MD
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Clinical Considerations for the Diagnosis of Endometriosis
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.